JP2024517607A5 - - Google Patents

Info

Publication number
JP2024517607A5
JP2024517607A5 JP2023562936A JP2023562936A JP2024517607A5 JP 2024517607 A5 JP2024517607 A5 JP 2024517607A5 JP 2023562936 A JP2023562936 A JP 2023562936A JP 2023562936 A JP2023562936 A JP 2023562936A JP 2024517607 A5 JP2024517607 A5 JP 2024517607A5
Authority
JP
Japan
Prior art keywords
sequence
nuclease system
manipulated
nucleic acid
endonuclease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023562936A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517607A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/027124 external-priority patent/WO2022232638A2/en
Publication of JP2024517607A publication Critical patent/JP2024517607A/ja
Publication of JP2024517607A5 publication Critical patent/JP2024517607A5/ja
Pending legal-status Critical Current

Links

JP2023562936A 2021-04-30 2022-04-29 Ruvcドメインを有する酵素 Pending JP2024517607A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163182438P 2021-04-30 2021-04-30
US63/182,438 2021-04-30
PCT/US2022/027124 WO2022232638A2 (en) 2021-04-30 2022-04-29 Enzymes with ruvc domains

Publications (2)

Publication Number Publication Date
JP2024517607A JP2024517607A (ja) 2024-04-23
JP2024517607A5 true JP2024517607A5 (cg-RX-API-DMAC7.html) 2025-05-01

Family

ID=83847352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023562936A Pending JP2024517607A (ja) 2021-04-30 2022-04-29 Ruvcドメインを有する酵素

Country Status (10)

Country Link
US (1) US20240110167A1 (cg-RX-API-DMAC7.html)
EP (1) EP4330386A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024517607A (cg-RX-API-DMAC7.html)
KR (1) KR20240004618A (cg-RX-API-DMAC7.html)
CN (1) CN117203332A (cg-RX-API-DMAC7.html)
AU (1) AU2022264921A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023022270A2 (cg-RX-API-DMAC7.html)
CA (1) CA3214222A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023012606A (cg-RX-API-DMAC7.html)
WO (1) WO2022232638A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10913941B2 (en) 2019-02-14 2021-02-09 Metagenomi Ip Technologies, Llc Enzymes with RuvC domains
CN119452085A (zh) 2021-08-27 2025-02-14 宏基因组学公司 具有ruvc结构域的酶
KR20240110603A (ko) 2021-11-24 2024-07-15 메타지노미, 인크. 엔도뉴클레아제 시스템
IL326604A (en) * 2023-09-13 2026-04-01 Metagenomi Therapeutics Inc Engineered and chimeric nucleases
WO2025106934A1 (en) * 2023-11-16 2025-05-22 Metagenomi, Inc. Enzymes with ruvc domains

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105209621B (zh) * 2012-12-12 2021-05-25 布罗德研究所有限公司 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
US9234213B2 (en) * 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
MX2019011215A (es) * 2017-03-24 2020-02-12 Curevac Ag Ácidos nucleicos que codifican proteínas asociadas a crispr y usos de los mismos.
KR20200124702A (ko) * 2018-02-23 2020-11-03 파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 신규한 cas9 오르소로그
KR20240007322A (ko) * 2019-02-14 2024-01-16 메타지노미, 인크. Ruvc 도메인이 존재하는 효소
US10913941B2 (en) * 2019-02-14 2021-02-09 Metagenomi Ip Technologies, Llc Enzymes with RuvC domains

Similar Documents

Publication Publication Date Title
JP2022520428A5 (cg-RX-API-DMAC7.html)
JP2024535672A5 (cg-RX-API-DMAC7.html)
US20230123754A1 (en) RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
JP2022552409A5 (cg-RX-API-DMAC7.html)
CA3128755C (en) Compositions and methods for treating hemoglobinopathies
JP2023542976A5 (cg-RX-API-DMAC7.html)
JP2020512845A5 (cg-RX-API-DMAC7.html)
JP2022531347A5 (cg-RX-API-DMAC7.html)
JP2022545385A5 (cg-RX-API-DMAC7.html)
JP2023519953A5 (cg-RX-API-DMAC7.html)
JP2025160487A5 (cg-RX-API-DMAC7.html)
JP6219944B2 (ja) 5’保護に依存した増幅
JP2024038327A5 (cg-RX-API-DMAC7.html)
JP2023533417A5 (cg-RX-API-DMAC7.html)
JP2024541402A5 (cg-RX-API-DMAC7.html)
JP2021532815A5 (cg-RX-API-DMAC7.html)
JP2024533940A5 (cg-RX-API-DMAC7.html)
JP2021530988A5 (cg-RX-API-DMAC7.html)
JP2002519038A5 (cg-RX-API-DMAC7.html)
US20230357790A1 (en) Self-targeting expression vector
JP2024500036A5 (cg-RX-API-DMAC7.html)
JP2021526798A5 (cg-RX-API-DMAC7.html)
JP2024515936A5 (cg-RX-API-DMAC7.html)
JP2024522086A5 (cg-RX-API-DMAC7.html)
JP2022536945A5 (cg-RX-API-DMAC7.html)